Medical condition
Advanced Or Recurrent Endometrial Cancer
Advanced Or Recurrent Endometrial Cancer is a medical condition tracked by NovaPharmaNews across 3 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- durvalumab (IMFINZI) Antineoplastic and immunomodulating agents (L01)
- olaparib (LYNPARZA) Antineoplastic and immunomodulating agents (L01)
- dostarlimab (JEMPERLI) Antineoplastic and immunomodulating agents (L01)